Company Overview and News

 
Retailers Can Forget About Being Bought by Steinhoff Now - Bloomberg Gadfly

2017-12-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Alibaba's Cainiao to raise more money; current funds good for up to 18 mths

2016-09-19 reuters
HANGZHOU, China, Sept 19 Cainiao Network, the logistics arm of Chinese e-commerce giant Alibaba Group Holding Ltd, will hold another round of fundraising but it is hoping that money raised in March will be sufficient for a year to 18 months.

 
European shares rise, lifted by banks and energy companies

2016-09-19 reuters
LONDON, Sept 19 European shares rose on Monday, marking a slight rebound after two straight weeks of losses, as gains in banking and energy company shares lifted the region's stock markets.

 
BRIEF-Groupe FNAC launches 650 million euros senior notes offering

2016-09-19 feeds.reuters
* Groupe FNAC launches 650 million euros senior notes offering Source text for Eikon: Further company coverage: (Gdynia Newsroom)

 
RPT-Bayer in $66 bln bet that farmers will back linked-up supplies

2016-09-19 reuters
FRANKFURT, Sept 16 Bayer's $66 billion purchase of Monsanto amounts to a long-term bet that farmers will grow to trust combinations of seeds and pesticides rather than continue to pick from ranges of separate products.

 
Activist Elliott raises the stakes in £600m Poundland takeover

2016-08-06 telegraph.co.uk
American hedge fund Elliott has upped its stake in Poundland, fuelling speculation that South African retail giant Steinhoff will be forced to up its £600m bid for the discount chain.

 
Statement re Offer for Darty plc

2016-08-01 londonstockexchange
THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO THE NEW FNAC SHARES EXCEPT ON THE BASIS OF INFORMATION PUBLISHED IN THE PROSPECTUS AND THE OFFER DOCUMENT

 
Darty

2016-07-19 londonstockexchange
Following the cash acquisition of Darty (UK, constituent) by Groupe FNAC (France, non-constituent) being declared unconditional in all respects, please see details of affected indexes and effective dates below:

1
Form 8.5 (EPT/RI) Replacement Groupe Fnac SA

2016-07-19 londonstockexchange
The ' Form 8.5 (EPT/RI)Groupe Fnac SA ' announcement released on 19/07/2016 at 11:55 under RNS No 6040E was released in error and should be disregarded.

 
Form 8.5 (EPT/RI)Replacement Groupe Fnac SA

2016-07-19 londonstockexchange
The ' Form 8.5 (EPT/RI)Groupe Fnac SA ' announcement released on 19/07/2016 at 11:57 under RNS No 6044E was released in error and should be disregarded.

 
Statement re Offer for Darty plc

2016-07-19 londonstockexchange
THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO THE NEW FNAC SHARES EXCEPT ON THE BASIS OF INFORMATION PUBLISHED IN THE PROSPECTUS AND THE OFFER DOCUMENT

 
Statement re Offer for Darty plc

2016-07-18 londonstockexchange
THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO THE NEW FNAC SHARES EXCEPT ON THE BASIS OF INFORMATION PUBLISHED IN THE PROSPECTUS AND THE OFFER DOCUMENT

 
Form 8.5 (EPT/RI)Groupe Fnac SA

2016-07-18 londonstockexchange
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

 
Form 8.5 (EPT/RI)Groupe Fnac SA

2016-07-18 londonstockexchange
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

 
Statement re Offer for Darty plc

2016-07-15 londonstockexchange
THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO THE NEW FNAC SHARES EXCEPT ON THE BASIS OF INFORMATION PUBLISHED IN THE PROSPECTUS AND THE OFFER DOCUMENT

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...